Innovative drug concept stocks remain active, NUCIEN PHARMA hits a 20% limit up
NUCIEN PHARMA hit a 20% limit up, Qizheng Tibetan Medicine and Han Commercial Group also hit the limit up, while Hitec Biology, Anke Biology, Huisheng Biology, Zhendong Pharmaceutical, Tebao Biology, and Zhenbao Island rose over 5%
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments